Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yu-Ju Gloria Meng"'
Autor:
Deepak Sampath, Jason Oeh, Shelby K. Wyatt, Tim C. Cao, Hartmut Koeppen, Jeffrey Eastham-Anderson, Liliane Robillard, Calvin C.K. Ho, Jed Ross, Guanglei Zhuang, Hani Bou Reslan, Philip Vitorino, Kai H. Barck, Sharon E. Ungersma, Jean Michel Vernes, Maresa Caunt, Nick Van Bruggen, Weilan Ye, Ulka Vijapurkar, Yu-Ju Gloria Meng, Napoleone Ferrara, Lori S. Friedman, Richard A.D. Carano
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 15, Iss 7, Pp 694-711 (2013)
The phosphatidylinositol 3-kinase (PI3K) pathway is a central mediator of vascular endothelial growth factor (VEGF)-driven angiogenesis. The discovery of small molecule inhibitors that selectively target PI3K or PI3K and mammalian target of rapamycin
Externí odkaz:
https://doaj.org/article/d0983e4f9813439184cf3adfb4b7c460
Autor:
Sharon E. Ungersma, Jean Michel Vernes, Lori Friedman, Liliane Robillard, Tim C. Cao, Hartmut Koeppen, Shelby K. Wyatt, Deepak Sampath, Jed Ross, Yu-Ju Gloria Meng, Napoleone Ferrara, Calvin Ho, Maresa Caunt, Richard A.D. Carano, Weilan Ye, Nick van Bruggen, Jeffrey Eastham-Anderson, Kai H. Barck, Philip Vitorino, Ulka Vijapurkar, Jason Oeh, Guanglei Zhuang, Hani Bou Reslan
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 15, Iss 7, Pp 694-711 (2013)
The phosphatidylinositol 3-kinase (PI3K) pathway is a central mediator of vascular endothelial growth factor (VEGF)-driven angiogenesis. The discovery of small molecule inhibitors that selectively target PI3K or PI3K and mammalian target of rapamycin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012b9e017e13a17f2f1fc1f6dcf0f9bd
http://www.sciencedirect.com/science/article/pii/S1476558613800644
http://www.sciencedirect.com/science/article/pii/S1476558613800644
Autor:
Ian Kasman, Jed Ross, Jo-Anne Hongo, Peter Haughney, Jean-Michel Vernes, Hani Bou Reslan, Mccutcheon Krista, Yongping Crawford, Xiumin Wu, Marcin Kowanetz, Thijs J. Hagenbeek, Napoleone Ferrara, Ganesh Kolumam, Suya Yang, Jenny Yao, Richard A.D. Carano, Christine Tan, Jeffrey Eastham-Anderson, Carlos Bais, Nick van Bruggen, Jean Philippe Stephan, Masabumi Shibuya, Yu-Ju Gloria Meng
Publikováno v:
Cell. 141(1)
SummaryIt has been recently reported that treatment with an anti-placenta growth factor (PlGF) antibody inhibits metastasis and primary tumor growth. Here we show that, although anti-PlGF treatment inhibited wound healing, extravasation of B16F10 cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65d6e063f17936bb3af3b932ad75cfe1
https://pubmed.ncbi.nlm.nih.gov/20371352
https://pubmed.ncbi.nlm.nih.gov/20371352
Publikováno v:
The FASEB Journal. 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfe5e9fa6b682d32fc440fd6946fcf97
https://doi.org/10.1096/fasebj.20.4.a536-b
https://doi.org/10.1096/fasebj.20.4.a536-b
Autor:
Stefka B Petkova, Yu-Ju Gloria Meng, Tomas J Sproule, Gregory J Christianson, Derry C Roopenian
Publikováno v:
The Journal of Immunology. 178:S245-S245
IgG antibodies modified for high binding affinity for their receptor FcRn have emerged as a major treatment for a wide array of both neoplastic and autoimmune diseases. The goal of this study was to analyze the effect of human IgG1 antibodies with en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fc59bc57abf82d0dfa3989e4b308f9a
https://doi.org/10.4049/jimmunol.178.supp.131.37
https://doi.org/10.4049/jimmunol.178.supp.131.37